ArticleOncoTargets and therapy2014

CP-673451, a platelet-derived growth-factor receptor inhibitor, suppresses lung cancer cell proliferation and migration.

Yuling Xi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.